Real-Time Oncology Review Speeds Supplements At US FDA, But Gives Modest Benefit For Novel Agents

 
• By Bridget Silverman
  
Fast Stream
RTOR has produced a steady stream of fast approvals. • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers